| Filed On | Filing |
|---|---|
| 21 May 2026 |
Form 4: Yarno Wendy L, Director
Granted 41,800 Common Stock Options · Granted 34,200 Restricted Stock Unit |
| 21 May 2026 |
Form 4: Shepard Jay, Director
Granted 41,800 Common Stock Options · Granted 34,200 Restricted Stock Unit |
| 21 May 2026 |
Form 4: Miller Ann Calby, Director
Granted 41,800 Common Stock Options · Granted 34,200 Restricted Stock Unit |
| 21 May 2026 |
Form 4: Weiner David B., Director
Granted 41,800 Common Stock Options · Granted 34,200 Restricted Stock Unit |
| 21 May 2026 |
Form 4: Zoth Lota S., Director
Granted 41,800 Common Stock Options · Granted 34,200 Restricted Stock Unit |
| 21 May 2026 |
Form 4: Dansey Roger D, Director
Granted 41,800 Common Stock Options · Granted 34,200 Restricted Stock Unit |
| 21 May 2026 |
Form 4: Benito Simon X, Director
Granted 41,800 Common Stock Options · Granted 34,200 Restricted Stock Unit |
| 21 May 2026 |
Form 4: Humeau Laurent, Chief Scientific Officer
Received 6,027 shares by exercise or conversion · Gave up 2,163 shares to cover exercise price or tax ($2.66K) · Granted 34,160 Common Stock Option · 1 more |
| 21 May 2026 |
Form 4: Sumner Michael John, Chief Medical Officer
Received 9,450 shares by exercise or conversion · Gave up 2,693 shares to cover exercise price or tax ($3.31K) · Granted 46,876 Common Stock Option · 1 more |
| 21 May 2026 |
Form 4: Kies Peter, CFO
Received 8,700 shares by exercise or conversion · Gave up 4,688 shares to cover exercise price or tax ($5.77K) · Granted 39,760 Common Stock Option · 1 more |
| 21 May 2026 |
Form 4: Shea Jacqueline Elizabeth, Director
Received 28,296 shares by exercise or conversion · Gave up 12,306 shares to cover exercise price or tax ($15.1K) · Granted 123,760 Common Stock Option · 1 more |
| 18 May 2026 |
Form 4: Shea Jacqueline Elizabeth, Director
Received 17,744 shares by exercise or conversion · Gave up 7,717 shares to cover exercise price or tax ($10K) |
| 18 May 2026 |
Form 4: Kies Peter, CFO
Received 4,771 shares by exercise or conversion · Gave up 2,571 shares to cover exercise price or tax ($3.34K) |
| 18 May 2026 |
Form 4: Humeau Laurent, Chief Scientific Officer
Received 4,771 shares by exercise or conversion · Gave up 1,712 shares to cover exercise price or tax ($2.23K) |
| 18 May 2026 |
Form 4: Sumner Michael John, Chief Medical Officer
Received 2,385 shares by exercise or conversion · Gave up 680 shares to cover exercise price or tax ($884) |
| 01 Apr 2026 |
Form 4: Sumner Michael John, Chief Medical Officer
Received 4,292 shares by exercise or conversion · Gave up 1,223 shares to cover exercise price or tax ($2.13K) |
| 05 Mar 2026 |
Form 4: Humeau Laurent, Chief Scientific Officer
Granted 26,840 Common Stock Option · Granted 21,560 Restricted Stock Unit |
| 05 Mar 2026 |
Form 4: Shea Jacqueline Elizabeth, Director
Granted 97,240 Common Stock Option · Granted 78,760 Restricted Stock Unit |
| 05 Mar 2026 |
Form 4: Sumner Michael John, Chief Medical Officer
Granted 36,832 Common Stock Option · Granted 29,608 Restricted Stock Unit |
| 05 Mar 2026 |
Form 4: Kies Peter, CFO
Granted 31,240 Common Stock Option · Granted 25,520 Restricted Stock Unit |
Loading...